Close Menu

myocardial infarction

The company aims to repurpose drugs by translating the mechanisms that allow hibernating animals to withstand the stresses of extended sleep.

A European study, published today in NEJM, used a POC, PCR-based system to perform CYP2C19 genotyping to guide platelet inhibitor therapy.

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.

Mungyeong mummy

A female mummy showing anatomical signs of atherosclerotic cardiovascular disease was found to carry risky versions of seven heart disease-related SNPs.

UK and Swedish researchers used a Mendelian randomization approach to study the association between serum calcium and heart disease and heart attack risk.

By studying variants in PCSK9, researchers reported the therapies targeting the gene would have some of the same effects as statins.

metspalu

The Estonian Genome Center aims to introduce genomic medicine via the country's online medical data infrastructure, according to Andres Metspalu, its director.

With exome sequencing data on nearly 10,000 individuals with or without early-onset myocardial infarction, researchers narrowed in on two genes prone to rare mutations in those at enhanced heart attack risk.

A retrospective study of patients seen over two years at the emergency department of Sweden's Karolinska University Hospital has demonstrated that using a very low cutoff point when measuring the protein biomarker cardiac troponin T could accurately rule out heart attack in a lar

NEW YORK (GenomeWeb Daily News) – A certain polymorphism in the stress-linked serotonin 2C receptor gene is linked to an increased risk of cardiovascular disease morbidity and mortality, researchers led by Duke University's Redford Williams

Pages

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.